Concepedia

Tamar Ginsburg-Shmuel

TG

4

Publications

90

Citations

4

H-Index

2010

Active since

Affiliations

Bar-Ilan University(Current)

Otto-von-Guericke University Magdeburg

Tamar Ginsburg-Shmuel is an author at Bar-Ilan University specializing in drug discovery, pharmacology, and medicine.

Top concepts

Publications per year

2010–2018

4

Publications

4

5-OMe-UDP is a Potent and Selective P2Y<sub>6</sub>-Receptor Agonist

Tamar Ginsburg-Shmuel, Michael Haas, Marlen Schumann et al. · Journal of Medicinal Chemistry · 2010 · 33 citations · Full text

UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety

Tamar Ginsburg-Shmuel, Michael Haas, Djordje Grbic et al. · Bioorganic & Medicinal Chemistry · 2012 · 28 citations · Full text

, , +7

A promising drug candidate for the treatment of glaucoma based on a P2Y6-receptor agonist

Tali Fishman Jacob, Vijay Singh, Mudit Dixit et al. · Purinergic Signalling · 2018 · 19 citations · Full text

, , +7

5-OMe-uridine-5′-O-(α-boranodiphosphate), a novel nucleotide derivative highly active at the human P2Y6 receptor protects against death-receptor mediated glial apoptosis

Michael Haas, Tamar Ginsburg-Shmuel, Bilha Fischer et al. · Neuroscience Letters · 2014 · 10 citations

, , +11

Rows per page

1–4 of 4